1. Home
  2. IVVD vs PANL Comparison

IVVD vs PANL Comparison

Compare IVVD & PANL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IVVD
  • PANL
  • Stock Information
  • Founded
  • IVVD 2020
  • PANL 1996
  • Country
  • IVVD United States
  • PANL United States
  • Employees
  • IVVD N/A
  • PANL N/A
  • Industry
  • IVVD Biotechnology: Pharmaceutical Preparations
  • PANL Marine Transportation
  • Sector
  • IVVD Health Care
  • PANL Consumer Discretionary
  • Exchange
  • IVVD Nasdaq
  • PANL Nasdaq
  • Market Cap
  • IVVD 351.6M
  • PANL 361.4M
  • IPO Year
  • IVVD 2021
  • PANL N/A
  • Fundamental
  • Price
  • IVVD $1.61
  • PANL $4.87
  • Analyst Decision
  • IVVD Strong Buy
  • PANL Strong Buy
  • Analyst Count
  • IVVD 5
  • PANL 1
  • Target Price
  • IVVD $6.11
  • PANL $9.00
  • AVG Volume (30 Days)
  • IVVD 6.2M
  • PANL 141.4K
  • Earning Date
  • IVVD 11-07-2025
  • PANL 11-06-2025
  • Dividend Yield
  • IVVD N/A
  • PANL 4.04%
  • EPS Growth
  • IVVD N/A
  • PANL N/A
  • EPS
  • IVVD N/A
  • PANL 0.16
  • Revenue
  • IVVD $46,210,000.00
  • PANL $579,781,169.00
  • Revenue This Year
  • IVVD $102.11
  • PANL $13.00
  • Revenue Next Year
  • IVVD $151.51
  • PANL N/A
  • P/E Ratio
  • IVVD N/A
  • PANL $30.72
  • Revenue Growth
  • IVVD 1941.08
  • PANL 15.10
  • 52 Week Low
  • IVVD $0.35
  • PANL $3.93
  • 52 Week High
  • IVVD $2.74
  • PANL $6.80
  • Technical
  • Relative Strength Index (RSI)
  • IVVD 46.79
  • PANL 46.20
  • Support Level
  • IVVD $1.74
  • PANL $4.81
  • Resistance Level
  • IVVD $2.00
  • PANL $5.03
  • Average True Range (ATR)
  • IVVD 0.24
  • PANL 0.14
  • MACD
  • IVVD -0.06
  • PANL 0.02
  • Stochastic Oscillator
  • IVVD 1.33
  • PANL 47.83

About IVVD Invivyd Inc.

Invivyd Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of antibody-based solutions for infectious diseases with pandemic potential. The company is developing antibodies to transcend the limits of naturally occurring immunity and provide superior protection from viral diseases, beginning with COVID-19. The company's product candidates are; ADG20 developed for the treatment and prevention of coronavirus disease, and VYD222, a monoclonal antibody candidate engineered, optimizing for potency and breadth of coverage, as well as providing a higher probability of retaining its utility for a longer duration in an evolving viral landscape.

About PANL Pangaea Logistics Solutions Ltd.

Pangaea Logistics Solutions Ltd and its subsidiaries provide seaborne drybulk logistics and transportation services. It transports various drybulk cargoes including grains, coal, iron, ore, pig, iron, hot briquetted iron, bauxite, alumina, cement clinker, dolomite, and limestone. The company provides ocean transportation services to clients utilizing an ocean-going fleet of motor vessels in the Handymax, Supramax, Ultramax, Panamax, and Post-Panamax segments. Its services include cargo loading, cargo discharge, vessel chartering, voyage planning, and technical vessel management. The company derives all of its revenues from contracts of affreightment, voyage charters and time charters. Geographically, it derives key revenue from the United States, followed by Canada, Germany, and others.

Share on Social Networks: